Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Financial Position

v3.21.2
Condensed Consolidated Statements of Financial Position - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Current:    
Cash and cash equivalents $ 56,621 $ 79,107
Restricted cash 454 353
Accounts receivable, net 1,620 1,676
Prepaids, advances and other 3,790 3,174
Other receivables 1,843 1,306
Inventories, net 13,148 10,190
Total current assets 77,476 95,806
Investment – Cansativa 1,528 1,553
Property, plant and equipment, net of accumulated depreciation of $4,365 and $3,356 for the six months ended June 30, 2021 and December 31, 2020, respectively 28,704 25,680
Intangible assets, net 23,498 24,279
Goodwill 18,508 18,508
Other non-current assets 58 52
Total Assets 149,772 165,878
Current:    
Accounts payable 3,258 4,429
Accrued expenses and other current liabilities 3,046 4,865
Current portion of Convertible notes 27,119 0
Warrant liability 22,736 19,061
Deferred revenue 435 870
Total current liabilities 56,594 29,225
Convertible notes 0 27,142
Loans and borrowings 6,559 6,701
Deferred revenue 1,565 1,167
Deferred tax liabilities 5,700 5,700
Other long-term liabilities 532 693
Total Liabilities 70,950 70,628
Shareholders’ equity    
Common shares, without par value, unlimited shares authorized: 25,629,641 and 24,883,024 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively 0 0
Preferred shares, without par value, unlimited shares authorized, nil shares issued and outstanding for each of June 30, 2021 and December 31, 2020 0 0
Additional paid-in capital 170,557 164,264
Accumulated deficit (91,735) (69,014)
Total equity attributable to shareholders 78,822 95,250
Total liabilities and shareholders' equity $ 149,772 $ 165,878